“Evaluation of EpiSwitch in predicting immunotherapy response​ in hepatocellular carcinoma and gastrointestinal tumors.”

Research by @MahmoudOuf94, Hongkun Wang, @ReetuMukherjiMD, @marshalj23, @RuthHe12, and others @LombardiCancer. #GI25